Safety of the second dose of the ChAdOx1 nCoV‐19 vaccine in people with persistent anti–platelet factor 4 antibodies

Uaprasert, Noppacharn, Trithiphen, Sasinipa, Sukperm, Autcharaporn, Akkawat, Benjaporn, Watanaboonyongcharoen, Phandee, Vichitratchaneekorn, Rattaporn, Tongbai, Thanisa, Jantarabenjakul, Watsamon, Paitoonpong, Leilani, Rojnuckarin, Ponlapat

Main content 1 Search 2 Footer 3

+A A -A High contrast

WHO COVID-19 Research Database

News/Update/Help

Advanced Search

The WHO Covid-19 Research Database is a resource created in response to the Public Health Emergency of International Concern (PHEIC). Its content remains searchable and spans the time period March 2020 to June 2023. Since June 2023, manual updates to the database have been discontinued.

Safety of the second dose of the ChAdOx1 nCoV‐19 vaccine in people with persistent anti–platelet factor 4 antibodies

Uaprasert, Noppacharn, Trithiphen, Sasinipa, Sukperm, Autcharaporn, Akkawat, Benjaporn, Watanaboonyongcharoen, Phandee, Vichitratchaneekorn, Rattaporn, Tongbai, Thanisa, Jantarabenjakul, Watsamon, Paitoonpong, Leilani, Rojnuckarin, Ponlapat.

Research and practice in thrombosis and haemostasis ; 5(8), 2021.

Article in English | EuropePMC | ID: covidwho-1543579

Search on Google

Print

XML

Collection: Databases of international organizations Database: EuropePMC Topics: Vaccines Language: English Journal: Research and practice in thrombosis and haemostasis Year: 2021 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Search on Google

Print

XML

Collection: Databases of international organizations Database: EuropePMC Topics: Vaccines Language: English Journal: Research and practice in thrombosis and haemostasis Year: 2021 Document Type: Article